Publications



MOLECULAR IMAGING FOR EARLY PREDICTION OF RESPONSE TO SORAFENIB TREATMENT IN SARCOMA


Zhoulei Li, Ken Herrmann, Sabine Pirsig, Kathrin Philipp-Abbrederis, Martin Henninger, Michaela Aichler, Annette Feuchtinger, Axel Walch, Ambros J Beer, Ingo Ringshausen, Kelsey L Pomykala, Klemens Scheidhauer, Markus Schwaiger, Ulrich Keller, and Andreas K Buck. (15-12-2013).

LIMITED-PROJECTION-ANGLE HYBRID FLUORESCENCE MOLECULAR TOMOGRAPHY OF MULTIPLE MOLECULES


Karin Radrich, Pouyan Mohajerani, Johanna Bussemer, Markus Schwaiger, Ambros J. Beer and Vasilis Ntziachristos. (01-04-2014).

SORTING OUT PANDORA´S BOX: DISCERNING THE DYNAMIC ROLES OF LIVER MICROENVIRONMENT IN ONCOLYTIC VIRUS THERAPY FOR HEPATOCELLULAR CARCINOMA


Jennifer Altomonte, Oliver Ebert. (22-04-2014).

THERAPEUTIC TARGETING OF NATURALLY PRESENTED MYELOPEROXIDASE-DERIVED HLA PEPTIDE LIGANDS ON MYELOID LEUKEMIA CELLS BY TCR-TRANSGENIC T CELLS


R. Klar, S. Schober, M.. Rami, S. Mall, J. Merl, S.M. Hauck, M. Ueffing, A. Admon, J. Slotta-Huspenina, M. Schwaiger, S. Stevanovic, R.A.J. Oostendorp, D.H. Busch, C. Peschel and A.M. Krackhardt. (13-05-2014).

WEEK ONE FLT-PET RESPONSE PREDICTS COMPLETE REMISSION TO R-CHOP AND SURVIVAL IN DLBCL


Ken Herrmann, Andreas K. Buck, Tibor Schuster, Kathrin Abbrederis, Christina Blümel, Ivan Santi, Martina Rudelius, Hans-Jürgen Wester, Christian Peschel, Markus Schwaiger, Tobias Dechow and Ulrich Keller. (19-05-2014).

POSITRON EMISSION TOMOGRAPHIC MONITORING OF DUAL PHOSPHATIDYLINOSITOL-3-KINASE AND MTOR INHIBITION IN ANAPLASTIC LARGE CELL LYMPHOMA


Graf N, Li Z, Herrmann K, Weh D, Aichler M, Slawska J, Walch A, Peschel C, Schwaiger M, Buck AK, Dechow T, Keller U. (23-05-2014).

ADVANCED RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER: THE SODIUM IODIDE SYMPORTER AND OTHER EMERGING THERAPEUTIC TARGETS.


Spitzweg C, Bible KC, Hofbauer LC, Morris JC. (02-06-2014).

BET AND HDAC INHIBITORS INDUCE SIMILAR GENES AND BIOLOGICAL EFFECTS AND SYNERGIZE TO KILL IN MYC-INDUCED MURINE LYMPHOMA


Joydeep Bhadury, Lisa M. Nilsson, Somsundar Veppil Muralidharan, Lydia C. Green, Zhoulei Li, Emily M. Gesner, Henrik C. Hansen, Ulrich B. Keller, Kevin G. McLure and Jonas A. Nilsson. (16-06-2014).

MYC AND EGR1 SYNERGIZE TO TRIGGER TUMOR CELL DEATH BY CONTROLLING NOXA AND BIM TRANSCRIPTION UPON TREATMENT WITH THE PROTEASOME INHIBITOR BORTEZOMIB


Matthias Wirth, Natasa Stojanovic, Jan Christian, Mariel C. Paul, Roland H. Stauber, Roland M. Schmid, Georg Häcker, Oliver H. Krämer, Dieter Saur and Günter Schneider. (21-08-2014).

MYC-INDUCED SUMOYLATION IS A THERAPEUTIC VULNERABILITY FOR B-CELL LYMPHOMA


Alexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, Sabine Steidle, Franz X. Schaub, Martina Rudelius, Iina Laitinen, Lisa Nilsson, Andrei Goga, Christian Peschel, Jonas A. Nilsson, John L. Cleveland and Ulrich Keller. (25-09-2014).